Alex Biese's profile photo

Alex Biese

New Jersey

Senior Editor at CURE Magazine

Senior Editor of MJH Life Sciences’ CURE, NLGJA Excellence in Journalism Award winner, musician, work in progress.

Featured in: Favicon curetoday.com Favicon msn.com Favicon yahoo.com (+5) Favicon usatoday.com Favicon suntimes.com Favicon cincinnati.com Favicon knoxnews.com Favicon indystar.com Favicon desmoinesregister.com Favicon app.com

Articles

  • 1 week ago | curetoday.com | Alex Biese

    Antihistamines are associated with improvements in progression-free events and survival outcomes for patients with metastatic urothelial carcinoma (mUC) receiving Tecentriq (atezolizumab), research has shown. Drawing on data from 896 patients from the phase 2 IMvigor210 trial and phase 3 IMvigor211 trial, researchers published their findings in Urologic Oncology: Seminars and Original Investigations.

  • 2 weeks ago | businessandamerica.com | Alex Biese

    What is life like for someone after cancer? “Often it’s a series of physical adjustments,” Dr. Kevin Billingsley, surgical oncologist and chief medical officer at Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, told CURE.

  • 2 weeks ago | curetoday.com | Alex Biese

    What is life like for someone after cancer? “Often it’s a series of physical adjustments,” Dr. Kevin Billingsley, surgical oncologist and chief medical officer at Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, told CURE.

  • 1 month ago | nj.com | Alex Biese

    This summer, East Rutherford just may be the entertainment epicenter of the world. That’s thanks to the efforts of MetLife Stadium, which is set for a banner season starting with a two-night stand by Kendrick Lamar and Jersey’s own SZA this Thursday and Friday. “It’s going to be epic,” Ron VanDeVeen, President and CEO of MetLife Stadium, told NJ Advance Media. READ MORE: 59 concerts in 2025 that you cannot miss, including Billy Joel, Beyoncé & Luke BryanEpic may be a bit of an understatement.

  • 1 month ago | curetoday.com | Alex Biese

    Among previously treated patients with HER2-mutated, advanced non-small cell lung cancer (NSCLC), treatment with zongertinib showed durable responses and clinically meaningful results, according to data published in a news release from the biopharmaceutical company Boehringer Ingelheim. The findings were also featured in the official press program of the American Association for Cancer Research (AACR) Annual Meeting and published in The New England Journal of Medicine.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
2K
Tweets
11K
DMs Open
No
Alex Biese
Alex Biese @APBiese
15 Jan 25

Did you know that 81% of cancer cures touted on #TikTok are fake? Find out more about this in my latest for @cure_today & @MJHLifeSciences: https://t.co/2njUslyayh

Alex Biese
Alex Biese @APBiese
5 Dec 24

.@kaydaustin was diagnosed with a rare stage 4 cancer at the age of 29. She hopes her new book, “Too Young for Cancer,” inspires other patients to advocate for themselves. Learn more in my latest for @cure_today/@MJHLifeSciences https://t.co/B85fCDx9vA

Alex Biese
Alex Biese @APBiese
13 Nov 24

#DaveCoulier has non-Hodgkin lymphoma. Here’s what we know so far about the news from the actor best known as Uncle Joey on #FullHouse: https://t.co/iD5pPwpwVJ @cure_today @MJHLifeSciences